Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
None listed
Sponsors
State Ayurvedic College and Hospital, Lucknow
Eligibility
Inclusion criteria
Inclusion criteria: Patients will be selected between 21-50 yrs of age irrespective of sex, caste, religion. Patients with abdominal USG findings suggestive of Grade 1,2,3 fatty liver. All essential criteria with at least one non-essential criteria will be taken as inclusion criteria- At least 1 out of 5 underlying conditions- BMI more than or equal to 23 kg per m sq. in Asian people Or Waist Circumference more than or equal to 90 cm in men and more than or equal to 80 cm in women. Fasting serum glucose more than or equal to 100 mg per mL or 2-hour post load glucose more than or equal to 140 mg per dL or HbA1C more than or equal to 5.7 percentage or type 2 diabetes or treatment for type 2 diabetes (HbA1C upto 8.5 percentage). Blood Pressure more than or equal to 130 upon 85 mmHg or Specific anti-hypertensive drug treatment. Plasma triglycerides more than or equal to 150 mg/dL or lipid lowering treatment Plasma HDL-Cholesterol less than or equal to 40 mg per dL in males and less than or equal to 50 mg per dL in females or lipid lowering treatment. Patient with Discomfort in Right upper quadrant of abdomen. Patient voluntarily willing to sign the consent form for the clinical trial. Patient fit for Virechan Karma.
Exclusion criteria
Exclusion criteria: Patient not from the age group mentioned in the inclusion criteria. In pregnant and lactating women Patients having complication of Chronic Liver Disease, Liver Cirrhosis, Hepatocellular Carcinoma, Cholecystitis, Cholelithiasis. Patients suffering with Acute Hepatitis, Chronic Hepatitis, Drug Induced Hepatitis, Alcoholic Liver Disease, Malignant Jaundice, Diabetic Kidney Disease or other Renal Disorders. Patient having uncontrolled Hypertension, Diabetes, Dyslipidemia. Patient who are contraindicated for Virechan Karma. Patient having other pathology like Tuberculosis, AIDS, Malignancies and other Infectious diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of Virechan karma along with Oral administration of Rohitakadya Churna in treatment of Metabolic Dysfunction Associated Steatotic Liver Disease.Timepoint: at 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To get a better insight of the etiopathology of Metabolic Dysfunction associated Steatotic Liver Disease in terms of Ayurveda. To understand the effectiveness of Virechan Karma in relieving the symptoms in patients of Metabolic Dysfunction associated Steatotic Liver Disease. To understand the efficacy of Rohitakadya Churna . To assess the side effects of drugs if any. Timepoint: at 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks & 12 weeks | — |
Countries
India
Contacts
Public ContactDr Shachi Srivastava
State Ayurvedic College & Hospital Lucknow
Outcome results
None listed